Constance B. Moore
Known title: DirectorCIK: 0001209220
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
HR Faces Dividend Cut Risk as REITs Face Pressure. Healthcare Realty Trust is among seven high‑yield REITs flagged for possible dividend cuts, raising concerns for income‑focused investors. The company also set a date for its third‑quarter earnings call, giving analysts a chance to assess its financial health. These developments could influence how the market views HR’s dividend sustainability and earnings outlook.
Transaction History
| CVEO | ▲ Buy | Grant | 3,624 | $0 | 5/27/2026 | View on chart |
| HR | ▲ Buy | Grant | 6,683 | $135K | 5/19/2026 | View on chart |
| HR | ▲ Buy | Grant | 9,018 | $135K | 5/20/2025 | View on chart |
| CVEO | ▲ Buy | Grant | 6,021 | $0 | 5/14/2025 | View on chart |
| HR | ▼ Sell | Tax Withholding | 18,877 | $299K | 4/14/2025 | View on chart |
| HR | ▲ Buy | Grant | 69,022 | $1.2M | 12/9/2024 | View on chart |
| HR | ▲ Buy | Grant | 8,443 | $135K | 5/21/2024 | View on chart |
| CVEO | ▲ Buy | Grant | 5,051 | $0 | 5/15/2024 | View on chart |
| HR | ▲ Buy | Grant | 7,128 | $135K | 6/5/2023 | View on chart |
| CVEO | ▲ Buy | Grant | 5,947 | $0 | 5/17/2023 | View on chart |
| CVEO | ▼ Sell | Open Market | 5,406 | $124K | 3/6/2023 | View on chart |
| HR | ▲ Buy | Grant | 8,171 | $210K | 8/2/2022 | View on chart |
| CVEO | ▲ Buy | Grant | 4,879 | $0 | 5/18/2022 | View on chart |
| HR | ▲ Buy | Grant | 1,633 | $50K | 3/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Civeo (CVEO) receives new analyst coverage and price targets
Roth Capital began coverage of Civeo and issued a $39 price target. Northland Capital also started coverage, assigning an Outperform rating and a $42 target. Both firms' reports add fresh analyst attention to the stock. The targets sit above the recent 52‑week high of $36.50, suggesting expectations of further upside.
Civeo (CVEO) receives new analyst coverage and price targets. Roth Capital began coverage of Civeo and issued a $39 price target. Northland Capital also started coverage, assigning an Outperform rating and a $42 target. Both firms' reports add fresh analyst attention to the stock. The targets sit above the recent 52‑week high of $36.50, suggesting expectations of further upside.